We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$222M
AUM Growth
+$17.3M
Cap. Flow
+$6.69M
Cap. Flow %
3.02%
Top 10 Hldgs %
24.45%
Holding
157
New
13
Increased
80
Reduced
39
Closed
4

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$2.46M
2
AFL icon
Aflac
AFL
+$1.32M
3
CVX icon
Chevron
CVX
+$1.13M
4
KYE
Kayne Anderson Energy
KYE
+$934K
5
PM icon
Philip Morris
PM
+$312K

Sector Composition

Rank Sector Weight
1 Financials 14.24%
2 Industrials 12.98%
3 Technology 11.85%
4 Consumer Discretionary 11.43%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEL icon
101
Xcel Energy
XEL
$49.1B
$465K 0.21%
14,420
-163
-1% -$5.05K
KMP
102
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
$442K 0.2%
5,371
-198
-4% -$15.3K
DRI icon
103
Darden Restaurants
DRI
$22.1B
$420K 0.19%
10,147
-11
-0.1% -$487
BHI
104
DELISTED
Baker Hughes
BHI
$414K 0.19%
5,563
KMB icon
105
Kimberly-Clark
KMB
$35.9B
$410K 0.18%
3,841
RYN icon
106
Rayonier
RYN
$6.4B
$396K 0.18%
12,279
-6,007
-33% -$188K
EXC icon
107
Exelon
EXC
$46.9B
$389K 0.18%
14,965
-238
-2% -$6.07K
PFE icon
108
Pfizer
PFE
$141B
$384K 0.17%
13,654
+422
+3% +$12K
CSCO icon
109
Cisco
CSCO
$440B
$380K 0.17%
15,300
+3,225
+27% +$76.9K
DUK icon
110
Duke Energy
DUK
$98B
$367K 0.17%
4,942
+290
+6% +$20.9K
LVS icon
111
Las Vegas Sands
LVS
$30.3B
$361K 0.16%
4,740
-300
-6% -$22.8K
FIS icon
112
Fidelity National Information Services
FIS
$21.8B
$355K 0.16%
6,480
MDLZ icon
113
Mondelez International
MDLZ
$77.3B
$355K 0.16%
9,438
+402
+4% +$14.7K
SDY icon
114
State Street SPDR S&P Dividend ETF
SDY
$21.6B
$334K 0.15%
4,362
+89
+2% +$6.67K
BAX icon
115
Baxter International
BAX
$11.5B
$324K 0.15%
8,251
SI
116
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$304K 0.14%
2,300
BRK.B icon
117
Berkshire Hathaway Class B
BRK.B
$1.06T
$294K 0.13%
2,322
+50
+2% +$6.33K
CELG
118
DELISTED
Celgene Corp
CELG
$289K 0.13%
3,370
-90
-3% -$6.84K
SNA icon
119
Snap-on
SNA
$21.1B
$283K 0.13%
2,391
-325
-12% -$37.6K
WM icon
120
Waste Management
WM
$95.9B
$283K 0.13%
6,335
+425
+7% +$18.5K
ESRX
121
DELISTED
Express Scripts Holding Company
ESRX
$278K 0.13%
4,011
+1,100
+38% +$77.4K
PNFP icon
122
Pinnacle Financial Partners Inc
PNFP
$15B
$274K 0.12%
6,942
GSK icon
123
GSK
GSK
$101B
$261K 0.12%
+3,900
New +$264K
APD icon
124
Air Products & Chemicals
APD
$66.1B
$257K 0.12%
2,162
CL icon
125
Colgate-Palmolive
CL
$73.1B
$257K 0.12%
3,771
-158
-4% -$10.6K

Similar funds

Stonebridge Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Stonebridge Capital Advisors held 157 positions worth $222M, up 8.5% from $204M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors deployed $6.69M of net new capital in Q2 2014, opening 13 new positions and adding to 80 existing holdings. Its largest new stake was Citigroup: 20,055 shares worth $945K.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Allergan Inc, an estimated $2.46M trimmed.

  • Stonebridge Capital Advisors's largest Q2 2014 buy was Citigroup: 20,055 shares worth $945K.
  • Stonebridge Capital Advisors added most to Meta Platforms (Facebook) in Q2 2014, an estimated $1.48M increase.
  • Stonebridge Capital Advisors's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $2.46M.
  • Stonebridge Capital Advisors fully exited Aflac in Q2 2014, selling an estimated $1.32M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $222M portfolio in Q2 2014.
  • Stonebridge Capital Advisors opened 13 new positions and closed 4 in Q2 2014.
  • Stonebridge Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $222M.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.